v3.26.1
Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
CURRENT ASSETS:    
Cash and cash equivalents $ 76 $ 371
Marketable securities – InterCure Ltd. 772
Trade receivable (net of allowance for credit losses of $0 and $36 at December 31, 2025 and 2024, respectively) 99
Prepaid expenses and other current assets 22 98
Warrants, net 68
Total current assets 166 1,340
NON-CURRENT ASSETS:    
Fixed assets, net 187
Intangible assets, net 3,816
Goodwill 3,193
Long-term bank deposit 14
Total Non-current assets 7,210
Total assets 166 8,550
CURRENT LIABILITIES:    
Loans and credit from banking corporations 138
Accounts payable 151 790
Warrants, net 1,279
Convertible loan from shareholder 269
Total current liabilities 420 2,207
NON-CURRENT LIABILITIES:    
Warrants 689
Deferred tax liability, net 219
Total Non-Current liabilities 908
EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:    
Share capital - ordinary shares of NIS 0.1 par value: Authorized December 31, 2025 and 2024 - 1,450,000,000; Issued and outstanding - 946,243,356 on December 31, 2025 and 881,385,256 on December 31, 2024; 25,139 23,138
Additional paid in capital 140,219 141,286
Reserve from transactions with non-controlling interests 20 20
Accumulated deficit (165,632) (159,009)
Total equity (254) 5,435
Total liabilities and equity $ 166 $ 8,550